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With increasing demand for donor organs for trans-
plantation, machine perfusion (MP) promises to be a
beneficial alternative preservation method for donor
livers, particularly those considered to be of subopti-
mal quality, also known as extended criteria donor
livers. Over the last decade, numerous studies
researching MP of donor livers have been published
and incredible advances have been made in both
experimental and clinical research in this area. With
numerous research groups working on MP, various
techniques are being explored, often applying differ-
ent nomenclature. The objective of this review is to
catalog the differences observed in the nomenclature
used in the current literature to denote various MP
techniques and the manner in which methodology is
reported. From this analysis, we propose a standard-
ization of nomenclature on liver MP to maximize
consistency and to enable reliable comparison and
meta-analyses of studies. In addition, we propose a
standardized set of guidelines for reporting the
methodology of future studies on liver MP that will
facilitate comparison as well as clinical implementa-
tion of liver MP procedures.
Abbreviations: MP, machine perfusion; PRISMA,
Preferred Reporting Items for Systematic Reviews
and Meta-Analyses; SCS, static cold storage
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Introduction
In an effort to meet the demand for donor organs needed
for transplantation, livers considered to be of suboptimal
quality and function are increasingly being transplanted.
Given the increased vulnerability of these organs and the
potential injury incurred during procurement and storage/
transportation, machine perfusion (MP) is a promising
alternative to static cold storage (SCS), the current stan-
dard of care in donor liver preservation. Following the first
successful series of extra-corporeally perfused canine liver
grafts performed by Brettschneider and Starzl et al. in
1967 (1), MP has been explored as a method to achieve
the preservation of donor livers under conditions simulat-
ing normal in vivo physiology in an attempt to minimize
ischemia-related injury associated with SCS. Research into
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MP has established three major benefits: the capability to
preserve donor organs while providing them with oxygen
and nutrients at various temperatures (optimal and pro-
longed preservation); the ability to recondition and opti-
mize the function of donor organs, particularly extended
criteria organs, with, for instance, oxygen perfsufflation,
de-fatting techniques for steatotic livers and pharmaceuti-
cal intervention (organ resuscitation and function recov-
ery); and lastly, to provide the possibility of testing the
function and viability of the organ prior to transplantation
(ex situ viability testing) by MP at 37°C.
With the number of publications on liver MP to date
exceeding 500, the last 10 years has seen an incredible
advancement in both experimental and clinical research
into donor liver MP. Several groups have been exploring
different methods of MP with the major technique differ-
ences relating to the temperatures used and the provision
of oxygen and whether the technique is flow or pressure
controlled. Given that MP is a nascent technology with
many technical aspects continuing to be explored, adapted
and improved, the publications on MP have exhibited great
discrepancies. These include the nomenclature used to
describe the different MP techniques (abbreviations
included), the temperatures considered to be hypo-, sub-
normo, or normothermic and the manner in which certain
details of the methodology are reported. The absence of
standardized nomenclature and guidelines for reporting
technical details pertaining to MP gives rise to the rela-
tively large variation that exists among studies. This makes
it difficult to compare different studies, perform meta-ana-
lyses and, in some cases, attempt to reexecute the
methodology used.
With the number of clinical studies on MP of donor liv-
ers rapidly increasing, it is important that a consensus
is reached on the nomenclature applied and which nec-
essary aspects of the methodology should be included
in a paper. The objective of this review is to catalog the
differences observed in the nomenclature used in the
current literature to denote various techniques of liver
MP and the manner in which the methodology is
described. From our analysis, we aim to address these
discrepancies, propose recommendations for nomencla-
ture and develop a standardized set of guidelines for
the reporting methodology for future studies on MP of
donor livers.
Methods
Literature search strategy
A comprehensive literature search for all published articles regarding MP
of donor livers was performed using the PubMed, EMBASE, MEDLINE,
Web of Science, and Cochrane Library databases. The final date of the
search was February 17, 2015. To ensure all potentially relevant articles
were included in the search, no specific date limits were set. The search
was conducted using the medical subject heading (MeSH) terms and
Emtree keywords “machine perfusion, machine preservation, liver
transplantation, and hepatic transplantation” combined with free text
terms regarding machine perfusion of donor livers such as “hypothermic,”
“normothermic,” and “subnormothermic.”
Selection criteria and data collection
Study selection was performed independently by two authors (S.A.K and
R.J.P.) in a standardized fashion using the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) method (2). Study
inclusion was carried out in three phases. An initial title search was car-
ried out whereby relevant titles were screened and studies whose titles
were unrelated to the aims of this review were excluded. The abstracts
of the remaining studies were then acquired and independently assessed
for eligibility. Full papers of the abstracts regarded as potentially eligible
were retrieved and underwent complete review and assessment until a
final compilation of articles was made. For articles in which an inconsis-
tency between the two authors occurred, a discussion about these arti-
cles was held to reach to a consensus. Figure 1 illustrates the study
selection procedure and the inclusion and exclusion criteria.
Inclusion criteria:
• All articles on machine perfusion of donor livers
• Fully accessible articles written in English and published in scientific
journals
• Human and animal studies
Article titles identified in 
all databases n= 2265
Irrelevant titles 
excluded n= 1406
Abstracts
n= 859
Duplicates excluded n= 287
Irrelevant abstracts excluded n=
291
Full papers 
n= 254
Unfound full articles n=27
Irrelevant articles n= 86
Reviews n= 25
Non-English n= 16
Included articles 
n=127
Figure 1: Flow chart illustrating study selection and inclu-
sion procedure. Irrelevant titles included studies mainly involv-
ing in vivo perfusion (and not machine perfusion), in vitro cell
studies, follow-up studies on MP or studies involving analysis of
data from studies on MP of donor livers without including the
MP procedure description in the methodology.
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Exclusion criteria:
• Irrelevant to title and objective of review
• Non-English
• Articles about MP of other organs
• Full version inaccessible
Data extraction and analysis
The data from the included studies was assessed, with the main focus
of these articles being the Materials and Methods section. The primary
aim of this study was to investigate the manner in which the methodol-
ogy of these studies was reported and to determine how certain aspects
concerning the MP procedure were mentioned. The recommendations
and guidelines that this review provides were extensively discussed and
agreed on by all authors of this paper.
Results
Of the 2265 articles identified from the initial literature
search, 127 of these ultimately met all inclusion criteria
(Figure 1). These papers were published between 1997
and 2015 and constituted both animal and human clinical
studies. From our analyses, we observed several differ-
ences in the manner in which the same type of MP tech-
niques was referred to as well as marked variation in the
temperatures used. In the following paragraphs and
tables, we highlight and assess these differences as well
as provide recommendations to establish uniformity in
the manner in which data are reported.
Timing of machine perfusion
In all of the studies reviewed in this paper, MP was con-
ducted either for (almost) the entire duration of the
preservation phase of the transplantation process or
before or after a period of traditional SCS. A significant
majority of the research groups that conducted animal
studies (3–34) and studies in which the donor and recipi-
ent center was the same location (35) nearly eliminated
the SCS phase, thus perfusing donor organs immediately
after procurement until the point of implantation. The
remaining studies, particularly most human studies,
performed MP for various time periods after a few hours
of SCS (during transport of the organs from the donor to
recipient centers) or as a result of prolonged cold ische-
mia times due to various logistical or unforeseen circum-
stances (36–50). Interesting to note, as opposed to
performing MP for the entire preservation phase, the
first clinical studies conducted by Guarrera et al. and
Dutkowski et al. chose to focus on exclusively conduct-
ing MP after a period of traditional SCS and immediately
prior to implantation (<2 h prior) (35,40,45,46,51).
Nomenclature and abbreviations used to identify the
type of machine perfusion
As the pioneering technique of MP, a number of differ-
ent terms, as shown in Table 1, have been used to
describe hypothermic MP in the past two decades. Even
though the majority of the studies mention the term hy-
pothermic within the title and/or article itself, a number
of papers simply use the term machine perfusion, with-
out specific indication of the temperature used. Other
types of MP include subnormothermic and normothermic
perfusion. For all three major types of MP, despite refer-
ring to the same procedure, numerous abbreviations are
used to describe the type of MP performed (Table 1).
Additionally, for subnormothermic and normothermic
MP, a major difference lay in the additional emphasis of
whether these perfusions were performed extra corpore-
ally or not.
Temperatures used during machine perfusion
Although, in general, three types of MP can be recog-
nized (i.e. hypothermic, subnormothermic and normother-
mic), we noted marked inconsistency in the actual
temperatures denoted by these terms (see Table 2).
Despite including a description of the technique of MP, a
number of papers (7,15,52,53) failed to specify what par-
ticular temperatures were used in their respective stud-
ies while some descriptions used arbitrary and unspecific
Table 1: Nomenclature and abbreviations currently used for the different types of liver machine perfusion
Type of machine perfusion References
Hypothermic (oxygenated) machine perfusion (HMP) 1–8,15,22,24,26,30,31,35,41–46,48–50,56,71,72,80,82,88–99
Hypothermic oxygenated perfusion (HOPE) 8,9,13,34,51,61,100–107
Continuous hypothermic oxygenated machine perfusion (CHOP) 108
Machine perfusion (MP) or Machine perfusion preservation (MPP) 53,57,63,64,73–75,109–111
Cold perfusion 23
Subnormothermic machine perfusion (SMP) 11,112
Subnormothermic machine perfusion (SNMP) 3,10,18,39,76,113–115
Subnormothermic ex vivo liver perfusion (SNEVLP) 17
Subnormothermic machine perfusion (MP20) 60,65–67,116–118
Normothermic machine perfusion (NMP) 16,19,21,25,29,36–38,40,62,68,81,119–123
Normothermic extracorporeal perfusion (NELP) 12,14,77,124,125
Normothermic extracorporeal perfusion (NECMO) 83
Normothermic ex vivo liver perfusion (NEVLP) 5
Warm perfusion 33,54,55,62
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terms such as “warm,” “cold,” or “room temperature”
(23,33,39,54,55) to denote the temperatures used during
MP. Of the 58 studies on hypothermic MP, 26 (45%)
reported perfusing the livers at 4°C, whereas the rest
performed MP at different temperatures within the 0°C–
10°C range. All studies on subnormothermic MP were
generally conducted at temperatures between 20°C and
30°C. However, the majority of these studies reported
using 20°C or 21°C, which in all cases the authors
referred to as being room temperature. Normothermic
MP was primarily carried out at the physiological body
temperature of humans or the animal of study, although
small discrepancies were seen in the temperatures sta-
ted as being the physiological body temperature of the
different animals.
Other aspects of methodology
In addition to the discrepancies in temperature, analysis of
the literature exhibited variation in the description of cer-
tain technical aspects of the machine perfusion procedure.
For instance, seven studies lack a clear description of
whether the liver underwent single (via the hepatic artery
or portal vein) or dual perfusion (16,23,24,56–59). As
opposed to the vast majority (92%) of the studies that stip-
ulated the use of a pressure or flow controlled system and
provided specifications of the settings used, a number of
studies failed to specify this (7,12,16,24,56,59–65). All
studies that provided oxygenation during MP explicitly sta-
ted this in the methodology; however, a number of studies
went further to specifically outline the details such as the
O2/CO2 mixture or the oxygen tension (2,3,5,6,44,64–78)
as opposed to simply mentioning the presence of an
oxygenator within the MP system (6,11,18,20,22,24,59,
60,62,64–68,79–81). Lastly, a significant number of the
studies also clearly mentioned the type of pump used dur-
ing MP (2,3,5,6,26,64–67,69–78,82–84), which gives an
indication of the flow pattern through the liver.
Discussion
In an effort to initiate and facilitate a standardization of
nomenclature as well as to establish guidelines on the
experimental and clinical reporting of MP of donor livers,
this systematic literature review assessed the differ-
ences in the nomenclature, temperatures and techniques
currently used and reported in published articles.
The timing of machine perfusion
Given that the timing and duration of MP during the
entire preservation and transportation period is essen-
tially correlated to the specific benefits MP is intended to
provide to the organ, it is important that the period at
which MP is performed is specified, for instance, organ
reconditioning and optimization can be applied either
prior to or after static cold storage, whereas viability test-
ing is generally performed shortly before implantation.
It is evident from the reviewed literature that MP can be
performed mainly at three particular time points; (1)
immediately after organ procurement, before the organ
is stored on ice for transportation (prestatic cold storage);
(2) (shortly) before organ implantation, especially in
instances with longer cold ischemia times (poststatic cold
storage); and (3) for the entire preservation period
between procurement and implantation, thus (nearly)
eliminating the need for SCS. In the case of the latter
method, we propose the term preservation MP. When
applying preservation MP, a short period of SCS is still
required during and immediately after organ procurement,
when the organ is prepared for connection to the perfu-
sion device, and shortly before implantation to avoid
warm ischemia during the anastomosis time. We thus
propose to use the term preservation MP when the time
period of SCS either before or after MP is less than a
maximum of 3 h (Figure 2). This 3-h time frame is based
on the experience of the authors of this paper with vari-
ous techniques of machine perfusion. It was generally
agreed that in reality it normally takes approximately 1.5–
2 h from the point of in situ cold flush, donor hepatec-
tomy, back table procedure to connection of the organ
onto the perfusion device. However, there are a number
of cases in which this may be delayed, for example, in liv-
ers with aberrant arterial vasculature that require vascular
reconstructions, and thus extra back table time is needed
Table 2: Various temperatures currently used for the different
types of liver machine perfusion
References
Hypothermic temperatures
0°C–4°C 126
1°C–3°C 127
2°C  1°C 119
3°C–5°C 50
3°C–6°C 47,48
4°C 4,8,50,53,74,75,78,100,110,111
4°C–6°C 27,29,30,41,63
4°C–8°C 12,21,63
5°C 121
5°C–8°C 122–125
8°C 60,61
8°C–10°C 77
10°C 24,49,53–57,83,126
Subnormothermic temperatures
20°C 68,80,81,93,95,96,121,127
21°C 11,69,70,78,82,88,89,128
25°C 71
33°C 90
20°C–30°C 94
Normothermic temperatures
Porcine 38°C 100,101,106,116
Human 35.5°C–37.5°C 76
Rat 36.5°C–37°C 129
Human/rabbit/rat 37°C 9,52,74,75,102–105,110,114,130
Rat 37.5°C 14,121,125
(Porcine) 39°C 97
“Warm” 33,52
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before the liver can be connected to the device. This 3-h
time frame is therefore the recommended maximum time
period that allows for unavoidable circumstances that
may cause a delay before machine perfusion can be
started. Similarly, it generally takes 40–60 min to make
the vascular anastomoses in the recipient until reperfu-
sion can be initiated. When this is added to the time
needed to take a donor liver off the machine, flush out
machine perfusion fluid, remove the cannulas and per-
form the last back table work (i.e. trimming of vessels
and preparation of the venacava in the donor for piggy
back anastomosis), one may expect a total time period
of 1–3 h before graft reperfusion in the recipient
occurs. Therefore, this 3 h of SCS reflects a maximum
time period. If the duration of SCS is longer than 3 h
and MP is applied either prior (immediately after
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Figure 2: Charts illustrating classification of the timing of machine perfusion. MP conducted within 3 h of organ procurement and
followed by a period of SCS is considered as pre-SCS MP, whereas that performed after a period of at least 3 h of SCS preservation prior
to implantation is considered as post-SCS MP. Additionally, MP can be performed between periods of SCS. Duration of SCS and preserva-
tion MP conducted within the 3 h windows on either end of the procedure remains unspecified and can be widely varied. Lastly, MP can
also be performed for the entire preservation period (immediately after organ procurement until just before implantation).
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Figure 3: Graphic presentation of the change in the rate of metabolism with decreasing temperature. Based on Van’t Hoff’s
principle (expressed as Q10 ¼ k2=k1ð Þ10=ðt2t1Þ), this graph demonstrates the significantly reduced metabolism at hypothermic tempera-
tures (0°C–12°C). The vertical lines in the graphs indicate the lower endpoint of temperature ranges of the different types of MP
proposed. NMP; normothermic machine perfusion (35°C–38°C); SMP, subnormothermic machine perfusion (25°C–34°C); MMP,
mid-thermic machine perfusion (13°C–24°C); HMP, hypothermic machine perfusion (0°C–12°C).
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procurement) or after SCS (shortly before implantation),
we propose to call this pre-SCS MP and post-SCS MP,
respectively.
Nomenclature and abbreviations
A number of different terms and abbreviations have been
used in the observed studies describing generally similar
MP methods. In some of these cases, a few aspects
such as oxygenation or single/dual perfusion may have
differed and were incorporated. To minimize confusion
and tackle the heterogeneity in the nomenclature, we
believe that authors of future publications should avoid
adapting other aspects of perfusion into the nomencla-
ture and retain simplicity. Given the importance of speci-
fying certain aspects of MP performed, the choice to use
certain terms in the title and throughout the publication
remains within the discretion of the author, although it is
advised that the use of the standardized abbreviations
for the respective types of MP—HMP (hypothermic
machine perfusion), MMP (mid-thermic machine perfu-
sion), SMP (subnormothermic machine perfusion) and
NMP (normothermic machine perfusion)—be maintained.
Temperature ranges
As described in the Results section, experiments con-
ducted on MP of donor livers have generally been per-
formed at three temperature ranges: hypothermically at
0°C–10°C,subnormothermically at 20°C–33°C and nor-
mothermically at 35°C–38°C (depending on the species
used in study). Based on common practice of the various
research groups working on liver MP and following a dis-
cussion with the authors involved in this review, the fol-
lowing classification of the standardized temperature
ranges is proposed.
Hypothermic MP (0°C–12°C): All studies involving HMP
so far have been conducted at temperatures of 10°C
and below with the major reason being that the rate of
metabolism and enzymatic reactions in mammalian cells
decreases to rates as low as 20% or even less (85,86)
(Figure 3). The benefit of HMP is that it minimizes
preservation injury while improving organ viability and,
for oxygenated livers, replenishes adenosine tri-
phosphate (ATP) stores. Because the rates of numerous
energy dependent reactions of liver mitochondrial
enzymes exhibit a significant change at 12.5°C (87), the
proposed cut-off point for HMP is 12°C.
Midthermic MP (13°C–24°C) and subnormothermic
MP (25°C–34°C): The term subnormothermic has been
considered for temperature ranges varying between
12°C and 35°C even though MP was performed at
20°C–22°C in the majority of studies in which the
temperature was referred to as subnormothermic. This
broad temperature range shows a great difference in the
rate of metabolism at, for example, 12°C as compared to
33°C (Figure 2). Furthermore, it can be argued that
temperatures as low as 15°C, 18°C or 20°C are too low
to be considered as subnormothermic as not only does
this term suggest being slightly below normal body
temperature but also at such low temperatures a living
person would be defined as (extremely) hypothermic.
Whereas at higher temperatures such as 30°C–33°C, the
rate of metabolism increases close to 70% of the normal
rate at body temperature (Figure 3). Based on this,
we propose to use the term mid-thermic (13°C–24°C)
to distinguish the lower temperatures (0°C–12°C) from
the less physiologically abnormal subnormothermic
temperature range (25°C–34°C).
Table 3: Checklist with recommended guidelines for the
reporting of relevant aspects of the methodology used in liver
machine perfusion
1. Phase of
preservation
 Timing
○ Pre-SCS MP
○ Preservation MP
○ Post-SCS MP
 Duration of MP
○ Specified in hours/minutes
2. Environment
and temperature
 In situ
○ (Normothermic) Regional perfusion
 Ex situ:
○ Hypothermic MP (0°C–12°C)
○ Midthermic MP (13°C–24°C)
○ Subnormothermic MP (25°C–34°C)
○ Normothermic MP (35°C–38°C)
3. Technical
aspects
 Single or dual vessel perfusion
(hepatic artery/portal vein)
○ Continuous or pulsatile flow
 Pressure or flow controlled perfusion
○ Computerized or manually
controlled system
 Perfusion temperature
○ Specify temperature in °C
○ Specify any significant
temperature changes during MP
(e.g. gradual rewarming)
 Temperature control
○ Automated or manual
 Type of pump
○ Roller/centrifugal/peristaltic
4. Perfusion fluid
composition and
oxygenation
 Perfusion fluid components
○ Full description of the composition
of the perfusion fluid used1
 Oxygenation
○ Ambient air, pure (100%) oxygen,
or carbogen, other mixture
 Heparin, antibiotics and nutrients
 Any other interventions e.g. drugs
5. Pre- and
Post-MP phase
 Is organ flushed before and/or after MP?
○ Which fluid is used and how much?
○ At what temperature?
 Specify vessels used in flushing of
the organ
1Both at baseline as well as compounds that are continuously or
intermittently administered during perfusion.
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Normothermic MP (35°C–38°C): The term normo-
thermic should refer to the normal core body temperature
of the species used in the study, i.e. 37°C for human and
rodent studies and 38°C in studies with porcine models.
Ex vivo or ex situ MP
An additional aspect of MP that demonstrated particular
variation in the literature was the referral of MP as being
performed ex vivo or ex situ. Given that MP involves per-
fusion of donor livers outside the body of a deceased
donor, the term ex vivo, which refers to “outside of the
living body,” does not seem appropriate. Therefore, the
term ex situ, which refers to “outside original location/
position,” is proposed as a more representative descrip-
tion of what occurs during MP.
Other technical aspects and reporting guidelines
Along with discrepancies in the nomenclature and tem-
perature ranges, reporting of other aspects, particularly
technical aspects belonging to methodology, were
observed. Given the ongoing advancement in the field
of MP, it is important that certain methodological
aspects are explicitly stated to ensure that studies can
be reproduced as well as objectively compared with
each other. Moreover, with additional clinical trials cur-
rently being performed, this will facilitate future meta-
analyses with maximum validity and reliability. The
authors of this review reached a consensus on various
aspects of the MP procedure that were considered fun-
damental and developed a checklist that can be utilized
and referred to when preparing a report on liver MP
(Table 3). Important aspects in this checklist include
clear descriptions of the flushing technique, all of the
technical aspects of the MP procedure, type of perfu-
sion fluid used and clarification of the time point, dura-
tion and temperatures at which MP is conducted.
Furthermore, to make valid comparisons of experimental
outcomes, the manner in which data is presented and
described, particularly in the Results section of publica-
tions, is important. The selection of (clinically) relevant
endpoints during MP was not the objective of this
paper, but the reader is referred to other recent reviews
that have summarized the various types of biomarkers
that can be used during MP for graft viability assess-
ment (69,70). Naturally, in clinical trials traditional out-
come parameters such as graft and patient survival
rates, as well as hepatic and systemic postoperative
complications, will be relevant endpoints. In case of
donation after cardiac death (DCD) liver transplantation,
a major clinical endpoint should be the incidence of
postoperative biliary complications.
Conclusion
As experimental and clinical research into MP of donor
livers advances, a standardization of nomenclature and
reporting of technical aspects of MP is required to mini-
mize heterogeneity and to facilitate more reliable and
valid comparison analyses of studies. We hope this
paper provides a useful overview on current nomencla-
ture and will be helpful in the reporting of future research
studies on liver MP.
Disclosure
The authors of this manuscript have no conflicts of inter-
est to disclose as described by the American Journal of
Transplantation.
References
1. Yanaga K, Makowka L, Lebeau G, et al. A new liver perfusion
and preservation system for transplantation research in large
animals. J Invest Surg 1990; 3: 65–75.
2. Moher D, Shamseer L, Clarke M, et al. Preferred reporting
items for systematic review and meta-analysis protocols
(PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1.
3. Berendsen TA, Bruinsma BG, Lee J, et al. A simplified subnor-
mothermic machine perfusion system restores ischemically
damaged liver grafts in a rat model of orthotopic liver transplan-
tation. Transplant Res 2012; 1: 6.
4. Berendsen TA, Bruinsma BG, Puts CF, et al. Supercooling
enables long-term transplantation survival following 4 days of
liver preservation. Nat Med 2014; 20: 790–793.
5. Boehnert MU, Yeung JC, Bazerbachi F, et al. Normothermic
acellular ex vivo liver perfusion reduces liver and bile duct injury
of pig livers retrieved after cardiac death. Am J Transplant
2013; 13: 1441–1449.
6. Carnevale ME, Balaban CL, Guibert EE, Bottai H, Rodriguez JV.
Hypothermic machine perfusion versus cold storage in the res-
cuing of livers from non-heart-beating donor rats. Artif Organs
2013; 37: 985–991.
7. Compagnon P, Clement B, Campion JP, Boudjema K. Effects of
hypothermic machine perfusion on rat liver function depending
on the route of perfusion. Transplantation 2001; 72: 606–614.
8. Dutkowski P, Furrer K, Tian Y, Graf R, Clavien P. Novel short-
term hypothermic oxygenated perfusion (HOPE) system pre-
vents injury in rat liver graft from non-heart beating donor. Ann
Surg 2006; 244: 968–976; discussion 976-7.
9. Dutkowski P, Schonfeld S, Odermatt B, Heinrich T, Junginger
T. Rat liver preservation by hypothermic oscillating liver perfu-
sion compared to simple cold storage. Cryobiology 1998; 36:
61–70.
10. Fujiyoshi M, Taketomi A. Sub-normothermic machine perfusion
preservation for graft selection and therapy in a mouse liver
transplantation model. Hepatology 2014; 60: 241A–241A.
11. Gringeri E, Bonsignore P, Bassi D, et al. Subnormothermic
machine perfusion for non-heart-beating donor liver grafts
preservation in a swine model: A new strategy to increase the
donor pool? Transplant Proc 2012; 44: 2026–2028.
12. Habib MM, Hafez TS, Parkes HG, Seifalian AM, Fuller BJ,
Davidson BR. A comparison of bile composition from heart-
beating and non-heart-beating rabbit organ donors during
normothermic extracorporeal liver perfusion: Experimental
evaluation using proton magnetic resonance spectroscopy.
Transplant Proc 2004; 36: 2914–2916.
2938 American Journal of Transplantation 2016; 16: 2932–2942
Karangwa et al
13. Hessheimer AJ, Fondevila C, Maathuis MHJ, et al. Hypother-
mic oxygenated perfusion improves hepatocellular but causes
kupffer and endothelial cell injury in porcine DCD liver trans-
plant. Am J Transplant 2012; 12: 131.
14. Tolboom H, Pouw RE, Izamis M, et al. Recovery of warm
ischemic rat liver grafts by normothermic extracorporeal perfu-
sion. Transplantation 2009; 87: 170–177.
15. Jain S, Lee CY, Baicu S, et al. Hepatic function in hypothermi-
cally stored porcine livers: Comparison of hypothermic machine
perfusion vs cold storage. Transplant Proc 2005; 37: 340–341.
16. Jamieson RW, Zilvetti M, Roy D, et al. Hepatic steatosis and
normothermic perfusion-preliminary experiments in a porcine
model. Transplantation 2011; 92: 289–295.
17. Knaak JM, Spetzler VN, Goldaracena N, et al. Subnormother-
mic ex vivo liver perfusion reduces endothelial cell and bile
duct injury after donation after cardiac death pig liver transplan-
tation. Liver Transpl 2014; 20: 1296–1305.
18. Liu Q, Berendsen T, Izamis ML, Uygun B, Yarmush ML, Uygun
K. Perfusion defatting at subnormothermic temperatures in
steatotic rat livers. Transplant Proc 2013; 45: 3209–3213.
19. Liu Q, Nassar A, Farias K, et al. Sanguineous normothermic
machine perfusion improves hemodynamics and biliary epithe-
lial regeneration in donation after cardiac death porcine livers.
Liver Transpl 2014; 20: 987–999.
20. Matsuno N, Obara H, Watanabe R, et al. Rewarming preserva-
tion by organ perfusion system for donation after cardiac death
liver grafts in pigs. Transplant Proc 2014; 46: 1095–1098.
21. Nassar A, Liu Q, Farias K, et al. Ex vivo normothermic machine
perfusion is safe, simple, and reliable: Results from a large ani-
mal model. Surg Innov 2015; 22: 61–69.
22. Obara H, Matsuno N, Enosawa S, et al. Pretransplant screen-
ing and evaluation of liver graft viability using machine perfu-
sion preservation in porcine transplantation. Transplant Proc
2012; 44: 959–961.
23. Lauschke H, Olschewski P, Tolba R, Schulz S, Minor T. Oxy-
genated machine perfusion mitigates surface antigen expres-
sion and improves preservation of predamaged donor livers.
Cryobiology 2003; 46: 53–60.
24. Olschewski P, Tolba R, Akbar S, Minor T. Use of HTK solution
for hypothermic machine perfusion: An alternative for the
preservation of less than optimal donor livers? An experimental
study in rats. Transplant Proc 2003; 35: 767.
25. op den Dries S, Karimian N, Weeder PD, Porte RJ. Normother-
mic acellular machine perfusion and bile duct injury in pig livers
retrieved after cardiac death. Am J Transplant 2013; 13: 3289.
26. Op Den Dries S, Wiersma-Buist J, Leuvenink HGD, De Boer
MT, Lisman T, Porte RJ. Hypothermic oxygenated machine
preservation of livers from donation after cardiac death: Does it
reduce bile duct Injury? Liver Transpl 2012; 18: S184.
27. ‘t Hart NA, der van Plaats A, Leuvenink HGD, et al. Determina-
tion of an adequate perfusion pressure for continuous dual ves-
sel hypothermic machine perfusion of the rat liver. Transplant
Int 2007; 20: 343–352.
28. Vekemans K, Liu Q, Brassil J, Komuta M, Pirenne J, Monbaliu
D. Influence of flow and addition of oxygen during porcine liver
hypothermic machine perfusion. Transplant Proc 2007; 39:
2647–2651.
29. Xu H, Berendsen T, Kim K, et al. Excorporeal normothermic
machine perfusion resuscitates pig DCD livers with extended
warm ischemia. J Surg Res 2012; 173: E83–E88.
30. Luer B, Koetting M, Efferz P, Minor T. Role of oxygen during
hypothermic machine perfusion preservation of the liver.
Transpl Int 2010; 23: 944–950.
31. Fondevila C, Hessheimer AJ, Maathuis MJ, et al. Hypothermic
oxygenated machine perfusion in porcine donation after circula-
tory determination of death liver transplant. Transplantation
2012; 94: 22–29.
32. Reddy S, Greenwood J, Maniakin N, et al. Non-heart-beating
donor porcine livers: The adverse effect of cooling. Liver
Transpl 2005; 11: 35–38.
33. Brockmann J, Reddy S, Coussios C, et al. Normothermic perfu-
sion: A new paradigm for organ preservation. Ann Surg 2009;
250: 1–6.
34. Schlegel A, Graf R, Brockmann J, Clavien P, Dutkowski P. Res-
cue of liver grafts after cardiac arrest: First study comparing
warm versus cold machine perfusion strategies in rodent mod-
els of liver transplantation. Transplant Int 2013; 26: 52–52.
35. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic
machine preservation in human liver transplantation: The first
clinical series. Am J Transplant 2010; 10: 372–381.
36. Sutton ME, op den Dries S, Karimian N, et al. Criteria for viability
assessment of discarded human donor livers during ex vivo nor-
mothermic machine perfusion. PLoS ONE 2014; 9: e110642.
37. op den Dries S, Karimian N, Sutton ME, et al. Ex vivo normoth-
ermic machine perfusion and viability testing of discarded
human donor livers. Am J Transplant 2013; 13: 1327–1335.
38. op den Dries S, Karimian N, Porte RJ. Normothermic machine
perfusion of discarded liver grafts. Am J Transplant 2013; 13:
2504–2504.
39. Martins P, Bruinsma B, Farmer A, et al. Subnormothermic
machine perfusion for recovery and viability testing of the dis-
carded human liver. Transplant Int 2013; 26: 316.
40. Graham JA, Guarrera JV. “Resuscitation” of marginal liver allo-
grafts for transplantation with machine perfusion technology. J
Hepatol 2014; 61: 418–431.
41. Henry SD, Arrington BO, Nachbar E, Samstein B, Emond JC,
Guarrera JV. Hypothermic machine perfusion attenuates molec-
ular markers of preservation injury in human liver transplanta-
tion. Am J Transplant 2010; 10: 107–108.
42. Henry S, Arrington B, Chen SW, Lee HT, Emond JC, Guarrera
JV. Hypothermic machine perfusion reduces molecular damage
cascades in human liver transplantation. Hepatology 2009; 50:
637A–637A.
43. Guarrera J, Estevez J, Boykin J, et al. Hypothermic machine
perfusion of liver grafts for transplantation: Technical develop-
ment in human discard and miniature swine models. Transplant
Proc 2005; 37: 323–325.
44. Guarrera JV, Henry SD, Chen SWC, et al. Hypothermic
machine preservation attenuates ischemia/reperfusion markers
after liver transplantation: Preliminary results. J Surg Res 2011;
167: E365–E373.
45. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic
machine preservation facilitates successful transplantation of
“orphan” extended criteria donor livers. Am J Transplant 2015;
15: 161–169.
46. Henry SD, Nachber E, Tulipan J, et al. Hypothermic machine
preservation reduces molecular markers of ischemia/
reperfusion injury in human liver transplantation. Am J Trans-
plant 2012; 12: 2477–2486.
47. Bae C, Henry SD, Guarrera JV. Is extracorporeal hypothermic
machine perfusion of the liver better than the ‘good old ice-
box’? Curr Opin Organ Transplant 2012; 17: 137–142.
48. Tulipan JE, Stone J, Samstein B, et al. Molecular expression of
acute phase mediators is attenuated by machine preservation
in human liver transplantation: Preliminary analysis of effluent,
serum, and liver biopsies. Surgery 2011; 150: 352–360.
American Journal of Transplantation 2016; 16: 2932–2942 2939
Standardization of Nomenclature and Reporting of Liver Machine Perfusion
49. Henry SD, Guarrera JV. Protective effects of hypothermic
ex vivo perfusion on ischemia/reperfusion injury and transplant
outcomes. Transplant Rev 2012; 26: 163–175.
50. Bae C, Pichardo EM, Huang H, Henry SD, Guarrera JV. The
benefits of hypothermic machine perfusion are enhanced with
vasosol and alpha-tocopherol in rodent donation after cardiac
death livers. Transplant Proc 2014; 46: 1560–1566.
51. Dutkowski P, Schlegel A, de Oliveira M, Muellhaupt B, Neff F,
Clavien P. HOPE for human liver grafts obtained from donors
after cardiac death. J Hepatol 2014; 60: 765–772.
52. Butler AJ, Rees MA, Wight DG, et al. Successful extracorpo-
real porcine liver perfusion for 72 hr. Transplantation 2002; 73:
1212–1218.
53. Bessems M, Doorschodt BM, Kolkert JLP, et al. Preservation
of steatotic livers: A comparison between cold storage and
machine perfusion preservation. Liver Transpl 2007; 13: 497–
504.
54. Reddy SP, Bhattacharjya S, Maniakin N, et al. Preservation of
porcine non-heart-beating donor livers by sequential cold stor-
age and warm perfusion. Transplantation 2004; 77: 1328–1332.
55. Hara Y, Akamatsu Y, Maida K, et al. A new liver graft prepara-
tion method for uncontrolled non-heart-beating donors, combin-
ing short oxygenated warm perfusion and prostaglandin E1. J
Surg Res 2013; 184: 1134–1142.
56. Jain S, Xu H, Duncan H, et al. Ex-vivo study of flow dynamics
and endothelial cell structure during extended hypothermic
machine perfusion preservation of livers. Cryobiology 2004; 48:
322–332.
57. Lee CY, Jain S, Duncan HM, et al. Survival transplantation of
preserved non-heart-beating donor rat livers: Preservation by
hypothermic machine perfusion. Transplantation 2003; 76:
1432–1436.
58. Nagrath D, Xu H, Tanimura Y, et al. Metabolic preconditioning
of donor organs: Defatting fatty livers by normothermic perfu-
sion ex vivo. Metab Eng 2009; 11: 274–283.
59. Xu H, Zhang JX, Jones JW, Southard JH, Clemens MG, Lee
CY. Hypothermic machine perfusion of rat livers preserves
endothelial cell function. Transplant Proc 2005; 37: 335–337.
60. Boncompagni E, Gini E, Ferrigno A, et al. Decreased apoptosis
in fatty livers submitted to subnormothermic machine-perfusion
respect to cold storage. Eur J Histochem 2011; 55: e40.
61. Dutkowski R, Graf R, Clavien P. Rescue of the cold preserved
rat liver by hypothermic oxygenated machine perfusion. Am J
Transplant 2006; 6: 903–912.
62. St Peter SD, Imber CJ, Lopez I, Hughes D, Friend PJ. Extended
preservation of non-heart-beating donor livers with normothermic
machine perfusion. Br J Surg 2002; 89: 609–616.
63. Uchiyama M, Kozaki K, Nemoto T, et al. Liver transplantation
from non-heart-beating donors: Effect of machine perfusion
preservation and pentoxifylline. Transplant Proc 1998; 30:
3798–3800.
64. Uchiyama M, Matsuno N, Hama K, et al. Comparison between
nonpulsatile and pulsatile machine perfusion preservation in
liver transplantation from non-heart-beating donors. Transplant
Proc 2001; 33: 936–938.
65. Vairetti M, Ferrigno A, Rizzo V, et al. Subnormothermic
machine perfusion protects against rat liver preservation injury:
A comparative evaluation with conventional cold storage.
Transplant Proc 2007; 39: 1765–1767.
66. Tarantola E, Bertone V, Milanesi G, et al. Preservation of obese
rat livers by subnormothermic machine perfusion protects
dipeptidylpeptidase-IV activity and expression in the biliary tree.
Dig Liver Dis 2012; 44: S24.
67. Tarantola E, Bertone V, Milanesi G, et al. Dipeptidylpeptidase-
IV activity and expression reveal decreased damage to the
intrahepatic biliary tree in fatty livers submitted to subnormoth-
ermic machine-perfusion respect to conventional cold storage.
Eur J Histochem 2014; 58: 176–184.
68. op den Dries S, Karimian N, Sutton ME, et al. Successful ex-
vivo normothermic machine perfusion and viability testing of
discarded human donor livers. Transplant Int 2013; 26: 337.
69. Verhoeven CJ, Farid WR, de Jonge J, Metselaar HJ, Kazemier
G, van der Laan LJ. Biomarkers to assess graft quality during
conventional and machine preservation in liver transplantation.
J Hepatol 2014; 61: 672–684.
70. Schlegel A, Kron P, Dutkowski P. Hypothermic oxygenated
liver perfusion: Basic mechanisms and clinical application. Curr
Transplant Rep 2015; 2: 52–62.
71. Monbaliu D, Heedfeld V, Liu Q, et al. Hypothermic machine
perfusion of the liver: Is it more complex than for the kidney?
Transplant Proc 2011; 43: 3445–3450.
72. Henry SD, Arrington B, Samstein B, et al. Preservation/
reperfusion injury is attenuated by hypothermic machine perfu-
sion in human liver transplantation. Am J Transplant 2009; 9:
234–234.
73. Lee CY, Zhang JX, deSilva H, Coger RN, Clemens MG.
Heterogeneous flow patterns during hypothermic machine
perfusion preservation of livers. Transplantation 2000; 70:
1797–1802.
74. Bessems M, Doorschodt B, Dinant S, de Graaf W, van Gulik T.
Machine perfusion preservation of the pig liver using a new
preservation solution, polysol. Transplant Proc 2006; 38: 1238–
1242.
75. Bessems M, Doorschodt B, Hooijschuur O, van Vliet A, van
Gulik T. Optimization of a new preservation solution for
machine perfusion of the liver: Which is the preferred colloid?
Transplant Proc 2005; 37: 329–331.
76. Bruinsma BG, Berendsen TA, Izamis M, Yarmush ML, Uygun
K. Determination and extension of the limits to static cold stor-
age using subnormothermic machine perfusion. Int J Artif
Organs 2013; 36: 775–780.
77. Hafez TS, Habib MM, Seifalian AM, Fuller BJ, Davidson BR.
Near-infrared spectroscopic assessment of mitochondrial oxy-
genation status–comparison during normothermic extracorpo-
real liver perfusion by buffer only or buffer fortified with
washed red blood cells: An experimental study. Transplant
Proc 2004; 36: 1265–1267.
78. Dirkes MC, Post ICJH, Heger M, van Gulik TM. A novel oxy-
genated machine perfusion system for preservation of the liver.
Artif Organs 2013; 37: 719–724.
79. Shigeta T, Matsuno N, Huai-Che H, et al. A basic consideration
for porcine liver preservation using a novel continuous machine
perfusion device. Transplant Proc 2012; 44: 942–945.
80. Obara H, Matsuno N, Shigeta T, Hirano T, Enosawa S, Mizu-
numa H. Temperature controlled machine perfusion system for
liver. Transplant Proc 2013; 45: 1690–1692.
81. Imber CJ, St Peter SD, Lopez de Cenarruzabeitia I, et al.
Advantages of normothermic perfusion over cold storage in
liver preservation. Transplantation 2002; 73: 701–709.
82. Kim JS, Boudjema K, D’Alessandro A, Southard JH. Machine
perfusion of the liver: Maintenance of mitochondrial function
after 48-hour preservation. Transplant Proc 1997; 29: 3452–
3454.
83. Fondevila C, Hessheimer AJ, Maathuis MJ, et al. Superior
preservation of DCD livers with continuous normothermic per-
fusion. Ann Surg 2011; 254: 1000–1007.
2940 American Journal of Transplantation 2016; 16: 2932–2942
Karangwa et al
84. Lee CY, Zhang JX, deSilva H, Coger RN, Clemens MG. Hetero-
geneous flow patterns during hypothermic machine perfusion
preservation of livers. Transplantation 2000; 70: 1797–1802.
85. Bruinsma BG, Berendsen TA, Izamis M, Yarmush ML, Uygun K.
Determination and extension of the limits to static cold storage
using subnormothermic machine perfusion. Int J Artif Organs
2013; 36: 775–780.
86. Dirkes MC, Post ICJH, Heger M, van Gulik TM. A novel oxy-
genated machine perfusion system for preservation of the liver.
Artif Organs 2013; 37: 719–724.
87. Lee MP, Gear AR. The effect of temperature on mitochondrial
membrane-linked reactions. J Biol Chem 1974; 249: 7541–
7549.
88. Manekeller S, Schuppius A, Stegemann J, Hirner A, Minor T.
Role of perfusion medium, oxygen and rheology for endoplas-
mic reticulum stress-induced cell death after hypothermic
machine preservation of the liver. Transplant Int 2008; 21: 169–
177.
89. Monbaliu D, Liu Q, Libbrecht L, et al. Preserving the morphol-
ogy and evaluating the quality of liver grafts by hypothermic
machine perfusion: A proof-of-concept study using discarded
human livers. Liver Transpl 2012; 18: 1495–1507.
90. Monbaliu D, Liu Q, Libbrecht L, et al. Preservation of normal
morphology of human livers after 24 hours of hypothermic
machine perfusion. A first-in-man study. Transplant Int 2011;
24: 151.
91. Monbaliu D, Vekemans K, De Vos R, et al. Hemodynamic, bio-
chemical, and morphological characteristics during preservation
of normal porcine livers by hypothermic machine perfusion.
Transplant Proc 2007; 39: 2652–2658.
92. Monbaliu DR, Debbaut C, Hillewaert WJ, et al. Flow competi-
tion between hepatic arterial and portal venous flow during
hypothermic machine perfusion preservation of porcine livers.
Int J Artif Organs 2012; 35: 119–131.
93. op den Dries S, Sutton ME, Karimian N, et al. Hypothermic
oxygenated machine perfusion prevents arteriolonecrosis of
the peribiliary plexus in pig livers donated after circulatory
death. PLoS ONE 2014; 9: e88521.
94. op den Dries S, Leuvenink H, De Boer MT, Lisman T, Porte
RJ. Hypothermic oxygenated machine preservation of donor liv-
ers after prolonged ischemia in a porcine model of donation
after cardiac death. HPB 2012; 14: 482.
95. Henry SD, Tulipan JE, Stone J, et al. Quantification of inflam-
matory biomarkers in perfusion effluent collected during the
first liver machine perfusion clinical trial. Am J Transplant 2011;
11: 454–455.
96. Jain S, Lee SH, Korneszczuk K, et al. Improved preservation of
warm ischemic livers by hypothermic machine perfusion with
supplemented University of Wisconsin solution. J Invest Surg
2008; 21: 83–91.
97. Jomaa A, Gurusamy K, Siriwardana PN, et al. Does hypother-
mic machine perfusion of human donor livers affect risks of
sinusoidal endothelial injury and microbial infection? A feasibil-
ity study assessing flow parameters, sterility, and sinusoidal
endothelial ultrastructure. Transplant Proc 2013; 45: 1677–
1683.
98. Liu Q, Vekemans K, van Pelt J, et al. Discriminate liver warm
ischemic injury during hypothermic machine perfusion by pro-
ton magnetic resonance spectroscopy: A study in a porcine
model. Transplant Proc 2009; 41: 3383–3386.
99. Liu Q, Vekemans K, Iania L, et al. Assessing warm ischemic
injury of pig livers at hypothermic machine perfusion. J Surg
Res 2014; 186: 379–389.
100. de Rougemont O, Breitenstein S, Leskosek B, et al. One hour
hypothermic oxygenated perfusion (HOPE) protects nonviable
liver allografts donated after cardiac death. Ann Surg 2009;
250: 674–683.
101. Dutkowski P, Odermatt B, Heinrich T, et al. Hypothermic oscil-
lating liver perfusion stimulates ATP synthesis prior to trans-
plantation. J Surg Res 1998; 80: 365–372.
102. Schlegel A, Graf R, Clavien P, Dutkowski P. Hypothermic oxy-
genated perfusion (HOPE) protects from biliary injury in a rodent
model of DCD liver transplantation. J Hepatol 2013; 59: 984–991.
103. Schlegel A, Graf R, Kron P, Clavien P, Dutkowski P. Warm or
cold machine perfusion to rescue DCD liver grafts prior to
transplantation. Br J Surg 2014; 101: 18–19.
104. Schlegel AA, Graf R, Clavien P, Dutkowski P. Hypothermic oxy-
genated machine perfusion (HOPE) prevents biliary injury after
transplantation of DCD liver grafts. Liver Transpl 2013; 19: S86.
105. Schlegel A, de Rougemont O, Graf R, Clavien P, Dutkowski P.
Protective mechanisms of end-ischemic cold machine perfu-
sion in DCD liver grafts. J Hepatol 2013; 58: 278–286.
106. Schlegel A, Dutkowski P. Role of hypothermic machine perfu-
sion in liver transplantation. Transpl Int 2015; 28: 677–689.
107. Schlegel A, Kron P, Graf R, Clavien P, Dutkowski P. Hypother-
mic oxygenated machine perfusion (HOPE) down-regulates the
immune response in a rat model of liver transplantation. Liver
Transpl 2014; 20: S137–S138.
108. Lu L, Rao J, Zhou H, Wang X. Effect of continuous hypother-
mic oxygenated machine perfusion (CHOP) on liver graft from
donors after cardiac death (DCD) following liver transplantation.
Hepatology 2014; 60: 829A–829A.
109. Uchiyama M, Matsuno N, Nakamura Y, et al. Usefulness of
preservation by machine perfusion of liver grafts from non-
heart-beating donors-a porcine model. Transplant Proc 2003;
35: 105–106.
110. Bessems M, Doorschodt B, van Vliet A, van Gulik T. Improved
rat liver preservation by hypothermic continuous machine per-
fusion using Polysol, a new, enriched preservation solution.
Liver Transpl 2005; 11: 539–546.
111. Bessems M, Doorschodt B, van Vliet A, van Gulik T. Machine
perfusion preservation of the non-heart-beating donor rat livers
using polysol, a new preservation solution. Transplant Proc
2005; 37: 326–328.
112. Gringeri E, Polacco M, D’Amico FE, et al. A new liver auto-
transplantation technique using subnormothermic machine per-
fusion for organ preservation in a porcine model. Transplant
Proc 2011; 43: 997–1000.
113. Bruinsma BG, Sridharan GV, Weeder PD, et al. Dynamic char-
acterization of human livers during ex vivo machine perfusion.
Hepatology 2014; 60: 200A.
114. Bruinsma B, Sridharan G, Weeder P, et al. Indicators of liver
viability in the ex vivo perfused human liver. Transplantation
2014; 98: 373–374.
115. Bruinsma BG, Yeh H, Ozer S, et al. Subnormothermic machine
perfusion for ex vivo preservation and recovery of the human
liver for transplantation. Am J Transplant 2014; 14: 1400–1409.
116. Vairetti M, Ferrigno A, Carlucci F, et al. Subnormothermic
machine perfusion protects steatotic livers against preservation
injury: A potential for donor pool increase? Liver Transpl 2009;
15: 20–29.
117. Vairetti M, Ferrigno A, Carlucci F, et al. Subnormothermic
machine perfusion protects steatotic liver graft: Implications for
organ transplantation. Transplant Int 2007; 20: 280–280.
118. Tolboom H, Izamis ML, Sharma N, et al. Subnormothermic
machine perfusion at both 20 degrees C and 30 degrees C
American Journal of Transplantation 2016; 16: 2932–2942 2941
Standardization of Nomenclature and Reporting of Liver Machine Perfusion
recovers ischemic rat livers for successful transplantation. J
Surg Res 2012; 175: 149–156.
119. St Peter SD, Imber CJ, Kay J, James T, Friend PJ. Hepatic
control of perfusate homeostasis during normothermic extro-
corporeal preservation. Transplant Proc 2003; 35: 1587–1590.
120. op den Dries S, Karimian N, Sutton M, et al. Successful ex-vivo
normothermic machine perfusion and viability testing of dis-
carded human donor livers. Am J Transplant 2013; 13: 519.
121. Izamis ML, Tolboom H, Uygun B, Berthiaume F, Yarmush ML,
Uygun K. Resuscitation of ischemic donor livers with normoth-
ermic machine perfusion: A metabolic flux analysis of treat-
ment in rats. PLoS ONE 2013; 8: e69758.
122. op den Dries S, Karimian N, Sutton M, et al. Normothermic
oxygenated machine preservation reduces reperfusion injury of
DCD livers but seems less useful in DBD livers: A comparative
study in a rat model. Liver Transpl 2013; 19: S202.
123. op den Dries S, Karimian N, Sutton ME, et al. Normothermic
machine preservation reduces bile duct injury in DCD livers: A
comparative study in a rat model. Transplant Int 2013; 26: 57.
124. Tolboom H, Milwid JM, Izamis ML, Uygun K, Berthiaume F, Yar-
mush ML. Sequential cold storage and normothermic perfusion
of the ischemic rat liver. Transplant Proc 2008; 40: 1306–1309.
125. Tolboom H, Pouw R, Uygun K, et al. A model for normother-
mic preservation of the rat liver. Tissue Eng 2007; 13: 2143–
2151.
126. van der Plaats A, Maathuis MH, ‘T Hart NA, et al. The Gronin-
gen hypothermic liver perfusion pump: Functional evaluation of
a new machine perfusion system. Ann Biomed Eng 2006; 34:
1924–1934.
127. ‘t Hart N, van der Plaats A, Leuvenink H, et al. Hypothermic
machine perfusion of the liver and the critical balance between
perfusion pressures and endothelial injury. Transplant Proc
2005; 37: 332–334.
128. Belzer FO, Southard JH. Principles of solid organ preservation
by cold storage. Transplantation 1988; 45: 673–676.
129. Nishino H, Nakaya J, Nishi S, Kurosawa T, Ishibashi T. Temper-
ature-induced differential kinetic properties between an initial
burst and the following steady state in membrane-bound
enzymes: Studies on lathosterol 5-desaturase. Arch Biochem
Biophys 1997; 339: 298–304.
130. Lee MP, Gear ARL. The effect of temperature on mitochondrial
membrane-linked reactions. J Biol Chem 1974; 249: 7541–
7549.
2942 American Journal of Transplantation 2016; 16: 2932–2942
Karangwa et al
